摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-(+)-N-乙酰基-甲基苄胺 | 36283-44-0

中文名称
(R)-(+)-N-乙酰基-甲基苄胺
中文别名
(+)-N-(1-苯乙基)乙酰胺;(R)-(+)-n-乙酰基-1-甲基苄胺;(R)-(+)-N-乙酰基-1-甲基苄胺
英文名称
N-acetyl-1-phenylethylamine
英文别名
(R)-N-(1-Phenylethyl)acetamide;(R)-N-acetyl-α-phenethylamine;N-[(1R)-1-phenylethyl]acetamide
(R)-(+)-N-乙酰基-甲基苄胺化学式
CAS
36283-44-0
化学式
C10H13NO
mdl
——
分子量
163.219
InChiKey
PAVMRYVMZLANOQ-MRVPVSSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    102-103 °C
  • 沸点:
    290.31°C (rough estimate)
  • 密度:
    1.007
  • 溶解度:
    可溶于氯仿、二甲基亚砜
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2924299090
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    请将产品存放在阴凉干燥的环境中。

SDS

SDS:16dc514055d87abc0effbb70aa3e16ec
查看
Name: (R)-(+)-N-Acetyl-1-methylbenzylamine Material Safety Data Sheet
Synonym: None
CAS: 36283-44-0
Section 1 - Chemical Product MSDS Name:(R)-(+)-N-Acetyl-1-methylbenzylamine Material Safety Data Sheet
Synonym:None

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
36283-44-0 (R)-(+)-N-Acetyl-1-methylbenzylamine 100 unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 36283-44-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 102 - 103 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C10H13NO
Molecular Weight: 163.22

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 36283-44-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(R)-(+)-N-Acetyl-1-methylbenzylamine - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 36283-44-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 36283-44-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 36283-44-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    (R)-1-(4-甲基苯基)乙胺的合成方法
    摘要:
    本发明公开了一种(R)‑1‑(4‑甲基苯基)乙胺的合成方法,其包括如下步骤:在C4~C10一元醇溶剂中,碱金属氢氧化物的存在下,将化合物3进行脱酰基反应得到所述的(R)‑1‑(4‑甲基苯基)乙胺,即可;其中,R为乙酰基、丙酰基或丁酰基。本发明的合成方法成本低、步骤简单、操作安全、副产物少、后处理简单、中间产物和终产物均易于纯化、总收率较高、终产物纯度也较高并且易于实现工业化生产。
    公开号:
    CN108658784B
  • 作为产物:
    描述:
    (AR)-2,5-二甲氧基-A-甲基-苯甲胺manganese(IV) oxide三溴化硼 、 magnesium sulfate 、 三乙胺 作用下, 以 乙醚二氯甲烷乙酸乙酯 为溶剂, 反应 48.0h, 生成 (R)-(+)-N-乙酰基-甲基苄胺
    参考文献:
    名称:
    一种新型非天然手性助剂1-(2,5-二甲氧基苯基)乙胺的设计,合成和光学拆分。在亚胺的非对映选择性烷基化中的应用
    摘要:
    发现手性胺1-(2,5-二甲氧基苯基)乙胺是其醛亚胺与烷基金属的非对映选择性烷基化的有效手性助剂。手性助剂的1-(2,5-二甲氧基苯基)乙基可以通过乙酰化然后氧化得到的烷基化产物而除去,伴随着从手性助剂到最终产物的氨基转移。外消旋的1-(2,5-二甲氧基苯基)乙胺可以很容易地由1,4-二甲氧基苯合成,并通过与扁桃酸形成非对映异构体盐而拆分,从而得到两种对映体纯形式。
    DOI:
    10.1016/s0040-4020(99)00307-5
点击查看最新优质反应信息

文献信息

  • A Single Lipase-Catalysed One-Pot Protocol Combining Aminolysis Resolution and Aza-Michael Addition: An Easy and Efficient Way to Synthesise β-Amino Acid Esters
    作者:Fan Xu、Qiongsi Wu、Xiaoyang Chen、Xianfu Lin、Qi Wu
    DOI:10.1002/ejoc.201500760
    日期:2015.8
    was developed to obtain chiral β-amino acid esters with lipase B from Candida antarctica (CAL-B) as the only catalyst. This method is conducted under mild reaction conditions and is very easy to handle. After a series of detailed optimization studies, ten racemic aromatic or aliphatic amines were subjected to this one-pot procedure, and twelve chiral β-amino acid esters and ten chiral amides were successfully
    开发了一种结合 aza-Michael 加成和氨解拆分的新型一锅法,以来自南极念珠菌 (CAL-B) 的脂肪酶 B 作为唯一催化剂获得手性 β-氨基酸酯。该方法在温和的反应条件下进行,非常容易操作。经过一系列详细的优化研究,10 种外消旋芳香族或脂肪族胺经过此一锅法处理,成功合成了 12 种手性 β-氨基酸酯和 10 种手性酰胺,其 ee 值在理论产率下具有优异的值。放大程序也没有明显降低反应速率或对映选择性,这使得该方法适用于手性 β-氨基酸酯的大规模生产。
  • Asymmetric Synthesis of Nonracemic Primary Amines via Spiroborate-Catalyzed Reduction of Pure (<i>E</i>)- and (<i>Z</i>)-<i>O</i>-Benzyloximes: Applications toward the Synthesis of Calcimimetic Agents
    作者:Wenhua Ou、Sandraliz Espinosa、Héctor J. Meléndez、Silvia M. Farré、Jaime L. Alvarez、Valerie Torres、Ileanne Martínez、Kiara M. Santiago、Margarita Ortiz-Marciales
    DOI:10.1021/jo400371x
    日期:2013.6.7
    Highly enantiopure (1-aryl)- and (1-naphthyl)-1-ethylamines were synthesized by the borane-mediated reduction of single-isomeric (E)- and (Z)-O-benzyloxime ethers using the stable spiroborate ester derived from (S)-diphenyl valinol and ethylene glycol as the chiral catalyst. Primary (R)-arylethylamines were prepared by the reduction of pure (Z)-ethanone oxime ethers in up to 99% ee using 15% of catalyst
    使用衍生自稳定的螺硼酸酯,通过硼烷介导的单一异构体 ( E )- 和 ( Z ) -O-苄基肟醚的还原,合成了高对映体纯的 (1-芳基)-和 (1-萘基)-1-乙胺( S )-二苯基缬氨醇和乙二醇作为手性催化剂。伯 ( R )-芳基乙胺是通过使用 15% 的催化剂将纯 ( Z )-乙酮肟醚还原至 99% ee来制备的。描述了使用对映纯(1-萘-1-基)乙胺作为手性前体合成新的和已知的拟钙剂类似物的两种方便且容易的方法。
  • Kinetic resolution of amines with enantiopure 3-N,N-diacylaminoquinazolin-4(3H)-ones
    作者:Al-Sehemi, Abdullah G.、Atkinson, Robert S.、Fawcett, John
    DOI:10.1039/b105917n
    日期:2002.1.7
    The title compounds (DAQs) are chiral when the two N-acyl groups are different because of the absence of rotation around the N–N bond (a chiral axis). Enantiopure DAQs have been obtained by incorporation of a chiral centre in enantiopure form either into the substituent at the Q2-position or into one of the N-acyl groups, or into both, followed by separation of diastereoisomers. This separation is unnecessary in one case because conversion of the N-monoacylaminoquinazolinone (MAQ) into the DAQ is completely diastereoselective. Neither is separation of diastereoisomers necessary with 3-[N,N-di-(S)-2-acetoxypropanoylamino]-2-diphenylmethylquinazolin-4(3H)-one 37a: this DAQ 37a has its N–N bond rendered a chiral axis by the bias in its imide moiety wholly in favour of one exo/endo conformation.The high chemoselectivity exhibited by N,N-diacetyl- or N,N-dibenzoylaminoquinazolinones in reaction with the less hindered of two secondary amines (pyrrolidine in the presence of 1 eq. of piperidine) has a stereoselective counterpart: reaction of the above enantiopure DAQs enantioselectively with racemic amines leading to kinetic resolution. Using 1 eq. of DAQ and 2 eq. of amine, both the derivatised and unreacted amine enantiomers are recovered with high enantiomeric excess (ee) (better than 90% ee in some cases). Some of the higher ees are found in the recovered amides where non-chemoselective attack on both N-acyl groups of the DAQ has occurred: from the opposite configurations of the amine component in the two amides and from the low enantiopurity of the recovered unreacted amine, reaction of each of the N-acyl groups with complementary enantiomers of the amine is occurring (parallel kinetic resolution).Although higher ees are, in general, obtained using secondary amines, high ees are obtained in some cases using 1-phenylethylamine and, in particular, amino acid esters (valine and alanine).The sense of enantioselectivity in the reactions of these DAQs with amines is controlled by the configuration of the N–N axis: replacing the Q group in an N-(S)-2-acetoxypropanoyl-N-acetyl-bearing DAQ by phthalimide, thus eliminating the N–N chiral axis, drastically reduces the level of kinetic resolution.
    标题化合物(DAQs)在两个N-酰基团不同时是手性的,因为N-N键(一个手性轴)缺乏旋转。通过将手性中心以手性形式引入Q2-位点的取代基或其中一个N-酰基团,或两者中,随后分离diastereoisomers,得到了纯对映体的DAQs。在一个情况下,这种分离是不必要的,因为将N-单酰胺基喹唑啉酮(MAQ)转化为DAQ是完全立体选择性的。对于3-[N,N-di-(S)-2-乙酰氧基丙酰胺基]-2-二苯甲基喹唑啉-4(3H)-酮37a,也不需要分离diastereoisomers:这个DAQ 37a通过其亚胺部分的偏向完全倾向于一个exo/endo构象,使其N-N键成为一个手性轴。N,N-二乙酰基或N,N-二苯甲酰氨基喹唑啉酮在与两个次级胺中较少受到阻碍的胺(在存在1 eq.的哌啶的情况下使用吡咯烷)反应时表现出高度的化学选择性,这在立体选择性上有对应:上述纯对映体的DAQs与外消旋胺反应,导致动力学拆分。使用1 eq.的DAQ和2 eq.的胺,衍生化的和未反应的胺对映体都以高对映体过量(ee)回收(在一些情况下优于90% ee)。在一些回收的酰胺中发现较高的ee,其中非化学选择性地攻击DAQ的两个N-酰基团:从两个酰胺中胺组分的相反构型和回收的未反应胺的低对映纯度,每个N-酰基团与胺的互补对映体反应(并行动态拆分)。尽管通常使用次级胺得到较高的ee,但在某些情况下使用1-苯乙胺,特别是氨基酸酯(缬氨酸和丙氨酸)得到高ee。这些DAQs与胺反应的对映选择性的方向受N-N轴配置的控制:在带有N-(S)-2-乙酰氧基丙酰基-N-乙酰基的DAQ中,通过用邻苯二甲酰亚胺替换Q组,从而消除N-N手性轴,显著降低了动力学拆分的水平。
  • Chemoselective Acylation of Amines in Aqueous Media
    作者:Sarala Naik、Gitalee Bhattacharjya、Bandana Talukdar、Bhisma K. Patel
    DOI:10.1002/ejoc.200300620
    日期:2004.3
    Amines are efficiently acylated by both cyclic and acyclic anhydrides by dissolving them in an aqueous medium with the help of a surfactant, sodium dodecyl sulfate (SDS). Cyclic and acyclic anhydrides react with equal ease with an amine, and amines with various stereo-electronic factors react at the same rates with an anhydride. Chemoselective acylation of amines in the presence of phenols and thiols
    通过在表面活性剂十二烷基硫酸钠 (SDS) 的帮助下将胺溶解在水性介质中,胺被环状酸酐和无环酸酐有效地酰化。环状和无环酸酐与胺反应同样容易,具有各种立体电子因子的胺与酸酐以相同的速率反应。已经实现了在酚类和硫醇存在下胺的化学选择性酰化以及在酚存在下硫醇的化学选择性酰化。反应过程中不使用酸性或碱性试剂。分离酰化产物不需要色谱分离。在中性水性介质中反应,产物容易分离,副产物无害,使本方法成为一种绿色化学过程。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004)
  • B(C <sub>6</sub> F <sub>5</sub> ) <sub>3</sub> ‐Catalyzed Deoxygenative Reduction of Amides to Amines with Ammonia Borane
    作者:Yixiao Pan、Zhenli Luo、Jiahong Han、Xin Xu、Changjun Chen、Haoqiang Zhao、Lijin Xu、Qinghua Fan、Jianliang Xiao
    DOI:10.1002/adsc.201801447
    日期:2019.5.14
    The first B(C6F5)3‐catalyzed deoxygenative reduction of amides into the corresponding amines with readily accessible and stable ammonia borane (AB) as a reducing agent under mild reaction conditions is reported. This metal‐free protocol provides facile access to a wide range of structurally diverse amine products in good to excellent yields, and various functional groups including those that are reduction‐sensitive
    据报道,在温和的反应条件下,用易于获得且稳定的氨硼烷(AB)作为还原剂,将酰胺进行的首次B(C 6 F 5)3催化脱氧还原为相应的胺。该无金属方案可轻松获得各种结构多样的胺产品,且收率高至优异,并且对各种官能团(包括对还原敏感的官能团)均具有良好的耐受性。该新方法也适用于手性酰胺底物,而不会破坏对映体的纯度。BF 3  OEt 2助催化剂在该反应中的作用是通过酰胺-硼加合物的原位形成来活化酰胺羰基。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐